New York, Feb 25, 2026, 06:06 EST — Premarket
XWELL Inc shares were up about 124% at around $0.85 in premarket trading on Wednesday, extending a volatile stretch for the thinly traded Nasdaq-listed stock. (StockAnalysis)
XWELL said late Tuesday it signed a securities purchase agreement with a series of American Ventures, LLC in a private placement expected to bring in about $31.3 million in gross proceeds. The deal includes Series H convertible preferred stock and warrants, and is priced “at the market” under Nasdaq rules, the company said. XWELL said it plans to use the net proceeds to repurchase certain notes, redeem its Series G preferred stock, redeem certain outstanding warrants, and fund working capital, with Dominari Securities acting as placement agent. (GlobeNewswire)
That cash figure matters because the company’s equity is tiny at current prices. XWEL closed Tuesday at $0.378, up 10.85% from a prior close of $0.341, implying a market value of roughly $2.18 million. (Wise)
The stock also landed on U.S. “unusual volume” screens after Tuesday’s move, a familiar setup for fast-money trading in micro-cap names. (TradingView)
Convertible preferred stock is a class of shares that can be swapped into common stock. Warrants are contracts that let the holder buy stock later at a fixed price, which can act like a hanging supply of future shares.
XWELL provides travel health and wellness services through brands that include XpresSpa and XpresCheck, according to company profile data. The shares have fallen roughly two-thirds over the past year, making any large financing headline a high-sensitivity event for the tape. (TradingView)
Some traders read “priced at the market” as a signal the company did not have to sell the paper at a steep discount. Others will fixate on the size and structure and try to game out how quickly the new securities could turn into common stock.
But the same structure that brings in cash can also pressure the share price. A big slug of potential new shares — especially warrants struck below the market — can weigh on a micro-cap stock once the initial squeeze fades.
In the regular session, investors will be watching whether the premarket jump holds through the open, and whether the stock can settle into a range that supports the financing rather than whipsawing lower.
The next hard catalyst is the expected closing of the private placement on or about Feb. 26, along with any follow-up disclosures tied to the deal. (Stock Titan)
